8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2019 / Randomized, placebo-controlled, multidose trial
In Qidong, China, 170 subjects were randomized to consume a placebo drink (n = 55) or one of three doses of a broccoli sprout beverage—full (n = 25), one-half (n = 35), or one-fifth (n = 55)—for 10 consecutive days. Median 24-h urinary output of sulforaphane metabolites was 24.6, 10.3, and 4.3 µmol across the three doses, respectively. The high-dose group showed a statistically significant 63.2% increase in urinary benzene mercapturic acids compared with controls over the 10-day period. Changes in the one-half dose (+11.3%) and one-fifth dose (-6.4%) groups were not significantly different from placebo.
Chen JG, Johnson J, Egner P, et al. Am J Clin Nutr, 2019. PMID 31268126
2016 / Randomized, double-blind, placebo-controlled study
Researchers conducted a randomized, double-blind, placebo-controlled trial to evaluate whether broccoli sprout homogenates (BSH, N = 13) altered peripheral blood immune responses compared to alfalfa sprout homogenate placebo (ASH, N = 16) following nasal LAIV inoculation. LAIV significantly reduced NKT and T cell populations, decreased NK cell CD56 and CD158b expression, and increased CD16 expression and cytotoxic potential on day 2. Compared to ASH, BSH supplementation further increased LAIV-induced granzyme B production in NK cells on day 2. Additionally, granzyme B levels appeared to be negatively associated with influenza RNA levels in nasal lavage fluid cells within the BSH group.
Müller L, Meyer M, Bauer RN, et al. PLoS One, 2016. PMID 26820305
2014 / Repeated measures crossover dietary intervention
In a repeated measures crossover study, young male smokers consumed 250 g/day of broccoli for 10 days. Broccoli intake significantly increased plasma levels of folate (+17%) and lutein (+39%), while no significant effect was observed for TNF-α, IL-6, IL-6sR, or adiponectin. Plasma CRP decreased by 48% (post-hoc analysis, p < 0.05) following the broccoli diet, independently of lutein and folate changes.
Riso P, Vendrame S, Del Bo' C, et al. Int J Food Sci Nutr, 2014. PMID 23992556
2014 / Clinical trial
Twenty-nine human subjects underwent an initial intranasal diesel exhaust particle challenge to assess inflammatory response. After a four-week washout, participants ingested broccoli sprout extract supplying 100 μmol sulforaphane daily for four days before undergoing a repeat particle challenge. Pretreatment with the extract decreased total cell counts in nasal lavage fluid by 54% (p < 0.001).
Heber D, Li Z, Garcia-Lloret M, et al. Food Funct, 2014. PMID 24287881
2014 / Randomized, double-blind, placebo-controlled trial
Healthy young adult smokers and nonsmokers ingested broccoli sprout homogenate or alfalfa placebo for four days, receiving live attenuated influenza virus intranasally on the second day. In smokers, broccoli sprout ingestion significantly lowered post-inoculation nasal lavage IL-6 responses (P = 0.03) and influenza sequence quantity (P = 0.01), while raising quinone oxidoreductase. In nonsmokers, a similar downward trend in viral quantity did not achieve statistical significance.
Noah TL, Zhang H, Zhou H, et al. PLoS One, 2014. PMID 24910991
2014 / Randomized controlled trial
In a 12-week randomized trial of 291 adults in China, drinking a daily broccoli sprout beverage significantly increased urinary excretion of glutathione conjugates of benzene by 61% and acrolein by 23% compared with placebo (P <= 0.01). Excretion of crotonaldehyde conjugates remained unchanged. Urinary sulforaphane metabolites showed that bioavailability was sustained throughout the 12-week daily dosing regimen.
Egner PA, Chen JG, Zarth AT, et al. Cancer Prev Res (Phila), 2014. PMID 24913818
2011 / Intervention study (pre-post biomarker evaluation)
Researchers developed an improved microtiter plate spectrophotometric assay to measure macrophage migration inhibitory factor (MIF) tautomerase activity and evaluated inactivation by isothiocyanates. In vitro, sulforaphane and other isothiocyanates were potent inactivators of MIF tautomerase. In human volunteers, administration of the sulforaphane precursor glucoraphanin almost completely abolished urinary tautomerase activity, which then recovered over many hours.
Healy ZR, Liu H, Holtzclaw WD, et al. Cancer Epidemiol Biomarkers Prev, 2011. PMID 21602309
2009 / Placebo-controlled dose escalation trial
A placebo-controlled dose escalation trial evaluated oral sulforaphane from a standardized broccoli sprout homogenate in human subjects. Dosing safely produced dose-dependent increases in upper airway nasal lavage cell RNA expression for GSTM1, GSTP1, NQO1, and HO-1, peaking at the 200 g sprout dose. In contrast, ingestion of control alfalfa sprouts lacking sulforaphane failed to stimulate Phase II enzyme induction.
Riedl MA, Saxon A, Diaz-Sanchez D Clin Immunol, 2009. PMID 19028145
2007 / Intervention trial with animal and human components
Researchers evaluated the protective effects of topical sulforaphane-rich extracts of 3-day-old broccoli sprouts against UV radiation in mice and humans. In six human subjects (three males and three females, 28-53 years of age), the extract up-regulated phase 2 enzymes and achieved a mean reduction in erythema across six UVR doses (300-800 mJ/cm² in 100 mJ/cm² increments) of 37.7% (range 8.37-78.1%; P = 0.025).
Talalay P, Fahey JW, Healy ZR, et al. Proc Natl Acad Sci U S A, 2007. PMID 17956979